| Stem definition | Drug id | CAS RN |
|---|---|---|
| immunosuppressants, rapamycin derivatives | 4778 | 572924-54-0 |
None
| Property | Value | Reference |
|---|---|---|
| Vd (Volume of distribution) | 3.20 L/kg | Lombardo F, Berellini G, Obach RS |
| CL (Clearance) | 1.10 mL/min/kg | Lombardo F, Berellini G, Obach RS |
| t_half (Half-life) | 46.30 hours | Lombardo F, Berellini G, Obach RS |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | L01EG03 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS ANTINEOPLASTIC AGENTS PROTEIN KINASE INHIBITORS Mammalian target of rapamycin (mTOR) kinase inhibitors |
| CHEBI has role | CHEBI:35610 | antineoplastic agents |
| CHEBI has role | CHEBI:68481 | mTOR inhibitors |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 10.5 | acidic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Serine/threonine-protein kinase mTOR | Kinase | INHIBITOR | IC50 | 9.70 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Kinase | Kd | 5.90 | CHEMBL |
| ID | Source |
|---|---|
| D08900 | KEGG_DRUG |
| CHEBI:82677 | CHEBI |
| CHEMBL2103839 | ChEMBL_ID |
| C515074 | MESH_SUPPLEMENTAL_RECORD_UI |
| 7884 | IUPHAR_LIGAND_ID |
| 8822 | INN_ID |
| DB06233 | DRUGBANK_ID |
| 48Z35KB15K | UNII |
| C2713007 | UMLSCUI |
| 11520894 | PUBCHEM_CID |
None